| Drug Type Interferons | 
| Synonyms- | 
| Target | 
| Action stimulants | 
| Mechanism IFNGR stimulants(Interferon gamma receptor stimulants) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 2 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Pulmonary Disease, Chronic Obstructive | Phase 2 | - | - | |
| Pulmonary Disease, Chronic Obstructive | Phase 2 | - | - | |
| Pulmonary Fibrosis | Phase 2 | - | - | |
| Pulmonary Fibrosis | Phase 2 | - | - | 
| Not Applicable | - | (High INFG expression) | lctnctjzcj(epnzfqgego) = njcatoawht emaftveian (jpswgbvuwa ) View more | Positive | 30 May 2017 | ||
| (Low INFG expression) | lctnctjzcj(epnzfqgego) = fajtwffxlh emaftveian (jpswgbvuwa ) View more | 






